In MANAGE trial, dabigatran lowered the risk of major vascular complications in patients with myocardial injury after non-cardiac surgery. During ESC Congress 2018 Philip J. Devereaux (Dpts of Health Research Methods, Evidence and Impact and Medicine, McMaster University, Hamilton, ON, Canada) describes the main findings of the trial.
- Practical implications of the COMPASS trial results
John W. Eikelboom Associate Professor - Department of Medicine McMaster University, Hamilton
- ESC 2017: highlights from EMANATE trial
Michael D. Ezekowitz Sidney Kimmel Medical College Thomas Jefferson University, Philadelphia